Apoptosis regulation by autophagy gene 5
Introduction
Apoptosis is the most common form of physiologic cell death in multicellular organisms. It is morphologically characterized by cell shrinkage, chromatin condensation, and membrane blebbing [1]. The main biochemical features are activation of intracellular proteases (in particular caspases) and internucleosomal DNA fragmentation. In most cases, cells undergo apoptosis in the absence of inflammation. Apoptosis can be mediated by death receptors or cell stress (e.g., anticancer drugs, ultraviolet light, gamma-irradiation, growth factor deprivation). Mitochondria play a key role in pro-apoptotic pathways that release pro-apoptotic proteins (e.g., cytochrome c, Smac) under the control of proteins of the Bcl-2 family [2]. The released mitochondrial pro-apoptotic proteins lead to increased caspase activation [3].
Autophagy is a process in a cell that serves to degrade long-lived proteins and to recycle cellular components to ensure survival during starvation. It is further characterized by extensive intracellular membrane remodeling, engulfing portions of the cytoplasm in large double-membrane vesicles, called autophagosomes. Autophagosomes subsequently fuse with lysosomes, leading to degradation of their content [4]. Autophagy is controlled by autophagy genes (Atgs). Besides its central role during starvation [5], [6], autophagy has been shown to play a role in tumor suppression [7], [8], pathogen killing [9], antigen presentation [10], and the regulation of the lifespan of the whole organism [11].
The involvement of autophagy in programmed cell death has been controversial. Autophagy is considered to be a survival mechanism. However, changes in autophagic activity can result in cell death (Fig. 1). Some, but not all, cancers have reduced autophagic activity [7], [8]. This may explain, why anticancer drugs, which increase autophagic activity, can induce both efficacy and drug resistance [12]. Moreover, since many human cancers exhibit mutations in pro-autophagy genes, sufficient autophagic activity might be important for tumor suppression [13]. On the other hand, autophagy enhances the survival of tumor cells under conditions of nutrient shortage and/or metabolic stress [14]. Taken together, the molecular mechanisms regulating cell survival and cell death within the process of autophagy are currently not understood.
Section snippets
Atg12–Atg5 and Atg8 (LC3)–PE conjugation systems
As mentioned above, autophagy is regulated by Atgs, which are mostly involved in the process of autophagosome formation and generate two ubiquitin-like conjugation systems: (1) the Atg12–Atg5 and (2) the Atg8 (LC3)–phosphatidylethanolamine (PE) systems (Fig. 2). Atg12 covalently links to Atg5. The mode of conjugation of Atg12 to Atg5 is similar to that of ubiquitination, since Atg12 is first activated by Atg7 (=ubiquitin-activating enzyme E1) and then transferred to Atg10 (=ubiquitin-activating
Atg5: a molecular switch factor between autophagy and apoptosis
Besides promoting autophagy, Atg5 may also play a role in a pro-apoptotic pathway. Therefore, although Atg5 might initially be involved in a survival process, it may later promote cell death. We noticed that overexpression of Atg5 increased the cell's susceptibility to undergo apoptosis following stimulation with several death triggers, including anticancer drugs [20]. The death stimulation resulted in calpain activation, leading to Atg5 cleavage. Truncated Atg5 induced cytochrome c release and
Atg6: role in autophagy and tumor development
Similarly to Atg5, Atg6 (Beclin 1) overexpression promotes autophagy [23] and its underexpression prevents autophagic cell death [24]. Atg6 is the first identified tumor suppressor protein that functions in the lysosomal degradation pathway of autophagy. Atg6 mapped to a tumor susceptibility locus on chromosome 17q21 that is monoallelically deleted in 40 to 75% of cases of sporadic breast, ovarian, and prostate cancer [25]. Moreover, Atg6 was shown to have tumor suppressor function in breast
Molecular interactions between Atg and Bcl-2 family members
Bcl-2 is an oncogene, which blocks apoptosis. However, Bcl-2 can also bind Atg6, whereby blocking Atg6-mediated autophagy and autophagic cell death [26]. Moreover, overexpression of Bcl-2 blocked autophagy in several systems [27]. In contrast, down-regulation of Bcl-2 triggers high levels of autophagy, which may result in autophagic cell death [26]. Taken together, Bcl-2 appears to be a negative regulator of autophagy, consisting with the view that cancer is often linked with insufficient
Conclusions and future prospects
Autophagy is an important process involved in both cell survival and cell death. Cancer is often linked to insufficient autophagy, suggesting that its role in cell death is particularly affected under these conditions. Therefore, drugs that induce autophagic activities in tumors might be useful. Indeed, several preclinical and clinical studies indicate that pharmacological inhibition of mTOR, which leads to the induction of autophagy, is associated with an anticancer effect [30]. Moreover,
Reviewers
Prof. Robert Friis, University of Berne, Department of Clinical Research, Tiefenaustrasse 120, Berne 3004, Switzerland.
Prof. Markus Simon, Max Planck Institute of Immunobiology, Stübeweg 51, Freiburg D-79108, Germany.
Prof. Mauro Piacentini, University of Rome, Department of Biology, Rome I-00133, Italy.
Conflict of interest
The authors have no conflict of interest.
Acknowledgement
Work in the authors’ laboratories is supported by the Swiss National Science Foundation (Grant no. 310000-107526 and 310000-112078).
Shida Yousefi, Ph.D. is a principle investigator at the Department of Pharmacology, University of Bern.
References (31)
- et al.
Autophagosomes: biogenesis from scratch?
Curr Opin Cell Biol
(2005) - et al.
Role and regulation of starvation-induced autophagy in the Drosophila fat body
Dev Cell
(2004) - et al.
Autophagy is a defense mechanism inhibiting BCG and mycobacterium tuberculosis survival in infected macrophages
Cell
(2004) - et al.
In vivo and in vitro reconstitution of Atg8 conjugation essential for autophagy
J Biol Chem
(2004) - et al.
Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death
J Biol Chem
(2005) - et al.
Cloning and genomic organization of Beclin 1, a candidate tumor suppressor gene on chromosome 17q21
Genomics
(1999) - et al.
Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy
Cell
(2005) - et al.
Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics
Br J Cancer
(1972) - et al.
The Bcl-2 protein family: arbiters of cell survival
Science
(1998) - et al.
IAP proteins: blocking the road to death's door
Nature Rev Mol Cell Biol
(2002)
The role of autophagy during the early neonatal starvation period
Nature
Promotion of tumorigenesis by heterozygous disruption of the Beclin 1 autophagy gene
J Clin Invest
Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor
Proc Natl Acad Sci USA
Endogenous MHC class II processing of a viral nuclear antigen after autophagy
Science
Autophagy genes are essential for dauer development and life-span extension in C. elegans
Science
Cited by (0)
Shida Yousefi, Ph.D. is a principle investigator at the Department of Pharmacology, University of Bern.
Hans-Uwe Simon, M.D., Ph.D. is a professor of pharmacology and Director of the Department of Pharmacology, University of Bern.